Clinical Trial Update: Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating hydroxychloroquine in combination with gemcitabine for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Hydroxychloroquine, Gemcitabine | Phase 2 | Status: UNKNOWN